Creatine Kinase Activity Assay

Cat# MA-CK

Size : 1PlateKit

Brand : RayBiotech

Contact local distributor :


Phone : +1 850 650 7790

Creatine Kinase Activity Assay

Creatine Kinase Activity Assay is a rapid, simple, reproducible, and standardized method for measuring total CK activity in biological samples. CK catalyzes the reversible phosphorylation of ADP, in the presence of creatine phosphate, to form ATP and creatine. The enzyme hexokinase (HK) uses the ATP produced to phosphorylate glucose, generating ADP and glucose-6-phosphate (G6P). G6P is then oxidized to 6-phosphogluconate, resulting in the production of NADH. The rate of NADH formation, measured at 340nm, is directly proportional to CK activity.
Contact Us for Bulk Request

Product Description

Specifications

Size1 Plate Kit, 2 Plate Kit, 5 Plate Kit
Compatible Sample TypesPlasma, Serum, Tissue Lysates, Cell Lysates
Quantitative/Semi-QuantitativeQuantitative
Research AreaCardiovascular Disease, Energy Metabolism
Shipping TypeBlue ice
Storage-20°C

Introduction

Creatine Kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme that catalyzes the reversible phosphorylation of creatine by ATP to form phosphocreatine and ADP. Phosphocreatine is the primary storage form of high-energy phosphate in muscle tissue. There are three different CK isoenzymes: CK-BB (CPK-1), which is primarily produced by the brain and lungs; CK-MB (CPK-2), which is primarily produced by heart muscle; and CK-MM (CPK-3), which is primarily produced by skeletal muscle.

Under normal circumstances, healthy individuals have very low levels of CK in their blood. Clinically, CK levels are often measured in emergency patients with chest pain and acute renal failure. An elevation of CK levels indicates muscle damage and has been linked to conditions such as injury, rhabdomyolysis, myocardial infarction, myositis, myocarditis, malignant hyperthermia and neuroleptic malignant syndrome. Conversely, lower levels may suggest alcoholic liver disease and rheumatoid arthritis.

The RayBio® Creatine Kinase Activity Assay Kit provides a rapid (5-minute), convenient method of detecting total creatine kinase activity in biological samples. The assay is based on enzyme-coupled reactions in which CK converts phosphocreatine and ADP to creatine and ATP, the generated ATP is used to phosphorylate glucose by hexokinase (HK) to generate glucose-6-phosphate, which is then oxidized by NADP in the presence of glucose-6-phosphate dehydrogenase. The resulting NADPH is proportional to the CK activity in the sample and is measured at 340 nm.

Kit Components

Component Size / Description
Microplate (Item A) One 96-well (12 strips x 8 wells) plate
Enzyme Solution 20 mL
Buffer Solution 4 mL
Sample Buffer 10 mL
Creatine Kinase Positive Control 20 µl

Additional Materials Required

  1. Microplate reader capable of measuring absorbance at 340 nm at 37°C
  2. 1:1 (v/v) ethanol:ethyl acetate
  3. Precision pipettes to deliver 2 µl to 1 ml volumes
  4. Distilled or deionized water
  5. Tubes to prepare sample dilutions

Assay Procedure Summary

  1. Prepare Reaction Solution according to Section VI Reagent Preparation, Step A
  2. Prepare Positive Control according to Section VI Reagent Preparation, Step B
  3. Pipette 200ul of Reaction Solution into the appropriate wells of the 96-well plate and incubate at 37°C for five minutes. (samples, blanks, and positive controls are recommended to be run in duplicate)
  4. Transfer 10ul of Sample, Blank (deionized water), and Positive Control to each well filled with Reaction Solution, mix and incubate at 37°C for two minutes.
  5. After two minutes, read and record the absorbance (A1) at 340nm 37°C. Repeat readings every minute for the next two minutes at 37°C (A2, A3).

Storage

The entire kit may be stored at -20°C for up to 6 months from the date of shipment. Avoid repeated freeze-thaw cycles.

citations

  • Targeting cellular senescence in dystrophin-/-/utrophin-/-double knockout mice improves musculoskeletal health and increases lifespan

    Species:
    Mouse
    Sample Type:
    Serum (mdx mice, ruxolitinib vs vehicle)
    Year:
    2025
    Journal Name:
    Pharmacological Research
    PubMed ID:
    41173171
  • Influence of ApoE genotype on doxorubicin-induced cognitive impairment in juvenile rats

    Species:
    Rat
    Sample Type:
    Serum
    Year:
    2025
    Journal Name:
    Scientific Reports
    PubMed ID:
    41436539